What is she best known for?
The fields of study she is best known for:
Her primary areas of study are Receptor, Endocrinology, Internal medicine, Progesterone receptor and Estrogen receptor.
Her Receptor research incorporates elements of Molecular biology, In vitro and Cell biology.
The various areas that she examines in her Endocrinology study include Hormone receptor, Transactivation, Antiestrogen, Tamoxifen and Nuclear receptor.
Her research combines Cytosol and Internal medicine.
Her studies in Progesterone receptor integrate themes in fields like Cancer cell, Cancer research and Glucocorticoid receptor, Glucocorticoid.
Her Estrogen receptor study frequently links to other fields, such as Estrogen.
Her most cited work include:
- Nuclear Receptor Coactivators and Corepressors (919 citations)
- Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. (716 citations)
- Phytoestrogen interaction with estrogen receptors in human breast cancer cells. (543 citations)
What are the main themes of her work throughout her whole career to date?
Kathryn B. Horwitz mainly focuses on Internal medicine, Endocrinology, Receptor, Progesterone receptor and Cancer research.
Her research in Estrogen, Breast cancer, Antiestrogen, Tamoxifen and Hormone are components of Internal medicine.
Her research investigates the connection with Endocrinology and areas like Cancer cell which intersect with concerns in Cell culture.
Her biological study spans a wide range of topics, including Nuclear receptor, Gene isoform and Phosphorylation, Cell biology.
As a part of the same scientific study, she usually deals with the Progesterone receptor, concentrating on Molecular biology and frequently concerns with Antibody and Monoclonal antibody.
The concepts of her Cancer research study are interwoven with issues in Tumor progression, Stroma, Signal transduction and Growth factor.
She most often published in these fields:
- Internal medicine (51.71%)
- Endocrinology (47.80%)
- Receptor (47.32%)
What were the highlights of her more recent work (between 2003-2021)?
- Cancer research (33.66%)
- Breast cancer (30.73%)
- Internal medicine (51.71%)
In recent papers she was focusing on the following fields of study:
Kathryn B. Horwitz mainly investigates Cancer research, Breast cancer, Internal medicine, Endocrinology and Cancer.
Her Cancer research study integrates concerns from other disciplines, such as Cancer cell, Tumor progression, Stroma and Cell.
Her Breast cancer study incorporates themes from Hormone, Primary tumor, Metastasis and Pathology.
Her Oncology research extends to Internal medicine, which is thematically connected.
Her work carried out in the field of Endocrinology brings together such families of science as Antiestrogen, Estrogen receptor, Fulvestrant and Epidermal growth factor.
Her Estrogen receptor study combines topics from a wide range of disciplines, such as Receptor, Tamoxifen and Breast disease.
Between 2003 and 2021, her most popular works were:
- The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-β signaling (186 citations)
- Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates. (175 citations)
- The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers. (143 citations)
In her most recent research, the most cited papers focused on:
Her main research concerns Cancer research, Endocrinology, Internal medicine, Progesterone receptor and Estrogen receptor.
She interconnects Tumor progression and Cancer in the investigation of issues within Cancer research.
Her Endocrinology research is mostly focused on the topic Estrogen.
Her Progesterone receptor research incorporates themes from Cellular differentiation, Receptor, Molecular biology, Cell biology and Progesterone receptor B.
Her work deals with themes such as Hormone, Tamoxifen, Signal transduction, Regulation of gene expression and Gene isoform, which intersect with Receptor.
Her research in Estrogen receptor intersects with topics in Cancer cell, CD44 and Growth factor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
